Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma

被引:7
作者
Russo, R.
Medbury, H.
Guiffre, A.
Englert, H.
Manolios, N.
机构
[1] Westmead Hosp, Dept Rheumatol, Westmead, NSW 2145, Australia
[2] Westmead Hosp, Dept Surg, Westmead, NSW 2145, Australia
关键词
CREST syndrome; fibrocytes; limited scleroderma; monocytes; progenitor cells;
D O I
10.1007/s10067-006-0461-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aetiology and pathogenesis of scleroderma is incompletely understood. Recently, a cell called the fibrocyte has been shown to be derived from circulating monocytes with the ability to produce collagen. The aim of this study was to evaluate differences in the cell surface characteristics of circulating fibrocyte progenitors (monocytes) in patients with limited scleroderma compared to controls. A case-control study was performed in eight patients with limited scleroderma, which were matched with eight controls. Three-colour flow cytometry was used to assess the relative expression of cell surface markers. Statistical analysis then compared the relative expression between the two groups. In this preliminary study, there were no significant differences in the expression of circulating monocyte surface molecules involved with cell transformation, function, or migration presumed to give rise to fibrocytes, in a population of patients with limited scleroderma. Various explanations for the results are discussed.
引用
收藏
页码:1136 / 1141
页数:6
相关论文
共 11 条
[1]   Peripheral blood fibrocytes: Differentiation pathway and migration to wound sites [J].
Abe, R ;
Donnelly, SC ;
Peng, T ;
Bucala, R ;
Metz, CN .
JOURNAL OF IMMUNOLOGY, 2001, 166 (12) :7556-7562
[2]   CD34+ SPINDLE-SHAPED CELLS SELECTIVELY DISAPPEAR FROM THE SKIN LESION OF SCLERODERMA [J].
AIBA, S ;
TABATA, N ;
OHTANI, H ;
TAGAMI, H .
ARCHIVES OF DERMATOLOGY, 1994, 130 (05) :593-597
[3]   PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[4]   CIRCULATING FIBROCYTES DEFINE A NEW LEUKOCYTE SUBPOPULATION THAT MEDIATES TISSUE-REPAIR [J].
BUCALA, R ;
SPIEGEL, LA ;
CHESNEY, J ;
HOGAN, M ;
CERAMI, A .
MOLECULAR MEDICINE, 1994, 1 (01) :71-81
[5]   Nephrogenic fibrosing dermopathy [J].
Cowper, SE ;
Su, LD ;
Bhawan, J ;
Robin, HS ;
LeBoit, PE .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2001, 23 (05) :383-393
[6]  
Douvas A, 1996, SYSTEMIC SCLEROSIS, P175
[7]   Nephrogenic fibrosing dermopathy in a renal transplant recipient with tubulointerstitial nephritis and uveitis [J].
Hauser, C ;
Kaya, G ;
Chizzolini, C .
DERMATOLOGY, 2004, 209 (01) :50-52
[8]  
LEROY EC, 1988, J RHEUMATOL, V15, P202
[9]   INCREASED COLLAGEN-SYNTHESIS BY SCLERODERMA SKIN FIBROBLASTS INVITRO - POSSIBLE DEFECT IN REGULATION OR ACTIVATION OF SCLERODERMA FIBROBLAST [J].
LEROY, EC .
JOURNAL OF CLINICAL INVESTIGATION, 1974, 54 (04) :880-889
[10]   Inhibition of fibrocyte differentiation by serum amyloid P [J].
Pilling, D ;
Buckley, CD ;
Salmon, M ;
Gomer, RH .
JOURNAL OF IMMUNOLOGY, 2003, 171 (10) :5537-5546